Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.5.3205

Urinary Bladder Cancer Risk Factors: A Lebanese Case-Control Study  

Kobeissi, Loulou Hassan (Mel and Enid Zuckerman College of Public Health, University of Arizona)
Yassine, Ibrahim Adnan (Faculty of Health Sciences, University of Balamand)
Jabbour, Michel Elias (Urology Department, St George Hospital University Medical Center)
Moussa, Mohamad Ahmad (Urology Division, Bahman Hospital)
Dhaini, Hassan Rida (Faculty of Health Sciences, University of Balamand)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.5, 2013 , pp. 3205-3211 More about this Journal
Abstract
Background: Bladder cancer is the second most incident malignancy among Lebanese men. The purpose of this study was to investigate potential risk factors associated with this observed high incidence. Methods: A case-control study (54 cases and 105 hospital-based controls) was conducted in two major hospitals in Beirut. Cases were randomly selected from patients diagnosed in the period of 2002-2008. Controls were conveniently selected from the same settings. Data were collected using interview questionnaire and blood analysis. Exposure data were collected using a structured face-to-face interview questionnaire. Blood samples were collected to determine N-acetyltransferase1 (NAT1) genotype by PCR-RFLP. Analyses revolved around univariate, bivariate and multivariate logistic regression, along with checks for effect modification. Results: The odds of having bladder cancer among smokers was 1.02 times significantly higher in cases vs. controls. The odds of exposure to occupational diesel or fuel combustion fumes were 4.1 times significantly higher in cases vs controls. The odds of prostate-related morbidity were 5.6 times significantly higher in cases vs controls. Cases and controls showed different clustering patterns of NAT1 alleles. No significant differences between cases and controls were found for consumption of alcohol, coffee, tea, or artificial sweeteners. Conclusions: This is the first case-control study investigating bladder cancer risk factors in the Lebanese context. Results confirmed established risk factors in the literature, particularly smoking and occupational exposure to diesel. The herein observed associations should be used to develop appropriate prevention policies and intervention strategies, in order to control this alarming disease in Lebanon.
Keywords
Bladder cancer; risk factors; case-control study; N-acetyltransferase 1; Lebanese;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Axtell C, Ward E, McCabe G, et al (1998). Underlying and multiple cause mortality in a cohort of workers exposed to aromatic amines. Am J Ind Med, 34, 506-11   DOI
2 Band P, Le N, MacArthur A, et al (2005). Identification of occupational cancer risks in British Columbia: a populationbased case-control study of 1129 cases of bladder cancer. J Occup Environ Med, 47, 854-8
3 Brennan P, Bogillot O, Cordier S, et al (2000). Cigarette smoking and bladder cancer in men: a pooled analysis of 11casecontrol studies. Int J Cancer, 86, 289-94   DOI
4 Butcher N, Ilett K, Minchin R (1998). Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations. Pharmacogenetics, 8, 67-72   DOI
5 Clavel J, Mandereau L, Limasset J, et al (1994). Occupational exposure to polycyclic aromatic hydrocarbons and the risk of bladder cancer. Int J Epidemiol, 23, 1145-53   DOI   ScienceOn
6 Deitz A, Doll M, Hein D (1997). A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1). Anal Biochem, 253, 219-24   DOI   ScienceOn
7 Dhaini H, Levy G (2000). Arylamine N-acetyltransferase 1 (NAT1) genotypes in a Lebanese population. Pharmacogenetics, 10, 79-83   DOI
8 Ferlay J, Shin H, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917   DOI   ScienceOn
9 Gago-Dominguez M, Bell D, Watson M, et al (2003). Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2. Carcinogenesis, 24, 483-9   DOI   ScienceOn
10 Hein D, Doll M, Fretland A, et al (2000). Molecular genetics and epidemiology of the NAT1 and NAT2 Acetylation Polymorphism. Cancer Epidemiol Biomarkers Prev, 9, 29-42
11 Hein D, Grant D, Sim E (2000). Update on consensus arylamine N-acetyltransferase gene nomenclature. Pharmacogenetics, 10, 291-2   DOI
12 Hoover R, Strasser P (1980). Artificial sweeteners and human bladder cancer: preliminary results. Lancet, 1, 837-40
13 Hughes N, Janezic S, McQueen K, et al (1998). Identification and characterization of variant alleles of human acetyltranferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. Pharmacogenetics, 8, 55-66   DOI
14 Iyer V, E. Harris R, Wynder E (1990). Diesel exhaust exposure and bladder cancer risk. Eur J Epidemiol, 6, 49-54   DOI
15 Jankovic S, Radosavljevic V (2007). Risk factors for bladder cancer. Tumori, 93, 4-12
16 Jemal R, Bray F, Center M, et al (2011). Global Cancer Statistics. CA Cancer J Clin, 61, 69-90   DOI
17 Kellen E, Zeegers M, Paulussen A, et al (2007). Does occupational exposure to PAHs, diesel and aromatic amines interact with smoking and metabolic genetic polymorphisms to increase the risk on bladder cancer?; The Belgian case control study on bladder cancer risk. Cancer Lett, 245, 51-60   DOI   ScienceOn
18 Kogevinas M, Mannetje A, Cordier S, et al (2003). Occupation and bladder cancer among men in Western Europe. Cancer Causes Control, 14, 907-14   DOI   ScienceOn
19 Kogevinas M, Trichopoulos D (2002). Urinary bladder cancer. In: Adami H, Hunter D, Trichopoulos D (eds). Textbook of cancer epidemiology. New York: Oxford University Press, 1, 446-66.
20 La Vecchia C, Negri E (1996). Nutrition and bladder cancer. Cancer Causes Control, 7, 95-100   DOI
21 MOPH, Lebanese Ministry of Public Health-Epidemiological Surveillance Program (2010). National Cancer Registry 2007 Cancer Data.
22 Mostafa M, Sheweita S, O'Connor P (1999). Relationship between Schistosomiasis and Bladder Cancer. Clin Microbiol Rev, 12, 97-111
23 Pashos C, Botteman M, Laskin B, et al (2002). Bladder cancer: epidemiology, diagnosis, and management. Cancer Pract, 10, 311-22   DOI   ScienceOn
24 Nakkash R, Khalil J, Afifi R (2011). The rise in narghile (shisha, hookah) waterpipe tobacco smoking: a qualitative study of perceptions of smokers and non smokers. Biomed Central Public Hlth, 14, 315
25 Negri E, La Vecchia C (2001). Epidemiology and prevention of bladder cancer. Eur J Cancer Prev, 10, 7-14   DOI   ScienceOn
26 Olfert S, Felknor S, Delclos G (2006). An updated review of the literature: risk factors for bladder cancer with focus on occupational exposures. South Med J, 99, 1256-63   DOI   ScienceOn
27 Ploeg M, Aben K, Kiemeney L (2009). The present and future burden of urinary bladder cancer in the world. World J Urol, 27, 289-93   DOI   ScienceOn
28 Renwick A (1993). A data-derived safety (uncertainty) factor for the intense sweetener, saccharin. Food Addit Contam, 10, 337-50   DOI   ScienceOn
29 Saade G, Abou Jaoude S, Afifi R, et al (2008). Patterns of tobacco use: results from the 2005 Global Youth Tobacco Survey in Lebanon. East Mediterr Hlth J, 16, 1280-9
30 Samanic C, Kogevinas M, Dosemeci M, et al (2006). Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev, 15, 1348-54   DOI   ScienceOn
31 Schoenberg J, Stemhagen A, Mogielnicki A, et al (1984). Casecontrol study of bladder cancer in New Jersey I. J Natl Cancer Inst, 72, 973-81
32 Shamseddine A, Musallam K (2010). Cancer Epidemiology in Lebanon. Middle East J Cancer, 1, 41-4
33 Wilhelm-Benartzi C, Christensen B, Koestler D, et al (2011). Association of secondhand smoke exposures with DNA methylation in bladder carcinomas. Cancer Causes Control, 22, 1205-13   DOI
34 Shamseddine A, Sibai A, Gehchan N, et al (2004). Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998. Ann Epidemiol, 14, 663-8   DOI   ScienceOn
35 Vineis P, Marinelli D, Autrup H, et al (2001). Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev, 10, 1249-52
36 Wakai K, Hirose K, Takezaki T, et al (2004). Foods and beverages in relation to urothelial cancer: case-control study in Japan. Int J Urol, 11, 11-9   DOI   ScienceOn
37 World Health Organization. Combating the tobacco epidemic. Geneva: WHO, 1999.
38 Yamaguchi N, Tazaki H, Okubo T, et al (1982). Periodic urine cytology surveillance of bladder tumor incidence in dyestuff workers. Am J Ind Med, 3, 139-48   DOI   ScienceOn
39 Yassine IA, Kobeissi L, Jabbour ME, et al (2012). N-Acetyltransferase 1 (NAT1) Genotype: a risk factor for urinary bladder cancer in a Lebanese population. J Oncol, 2012, 512976
40 Zeegers M, Kellen E, Buntinx F, et al (2004). The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol, 21, 392-401   DOI   ScienceOn
41 Zeegers M, Swaen G, Kant I, et al (2001). Occupational risk factors for male bladder cancer: results from a population based case cohort study in the Netherlands. Occup Environ Med, 58, 590-6   DOI
42 Zheng Y, Amr S, Saleh D, et al (2012). Urinary Bladder Cancer Risk Factors in Egypt: A Multicenter Case-Control Study. Cancer Epidemiol Biomarkers Prev, 21, 537-46   DOI